234 related articles for article (PubMed ID: 1284136)
1. A solid phase extraction technique for the isolation and identification of opiates in urine.
Huang W; Andollo W; Hearn WL
J Anal Toxicol; 1992; 16(5):307-10. PubMed ID: 1284136
[TBL] [Abstract][Full Text] [Related]
2. GC-MS confirmation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in urine.
Meatherall R
J Anal Toxicol; 1999; 23(3):177-86. PubMed ID: 10369327
[TBL] [Abstract][Full Text] [Related]
3. GC-MS quantitation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in blood.
Meatherall R
J Anal Toxicol; 2005; 29(5):301-8. PubMed ID: 16105253
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous identification and quantitation of codeine, morphine, hydrocodone, and hydromorphone in urine as trimethylsilyl and oxime derivatives by gas chromatography-mass spectrometry.
Broussard LA; Presley LC; Pittman T; Clouette R; Wimbish GH
Clin Chem; 1997 Jun; 43(6 Pt 1):1029-32. PubMed ID: 9191557
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, oxycodone, and 6-acetylmorphine in urine, serum, plasma, whole blood, and meconium by LC-MS-MS.
Coles R; Kushnir MM; Nelson GJ; McMillin GA; Urry FM
J Anal Toxicol; 2007; 31(1):1-14. PubMed ID: 17389078
[TBL] [Abstract][Full Text] [Related]
6. Distinction among eight opiate drugs in urine by gas chromatography-mass spectrometry.
Nowatzke W; Zeng J; Saunders A; Bohrer A; Koenig J; Turk J
J Pharm Biomed Anal; 1999 Sep; 20(5):815-28. PubMed ID: 10701990
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the usefulness of an oxycodone immunoassay in combination with a traditional opiate immunoassay for the screening of opiates in urine.
Gingras M; Laberge MH; Lefebvre M
J Anal Toxicol; 2010 Mar; 34(2):78-83. PubMed ID: 20223099
[TBL] [Abstract][Full Text] [Related]
8. Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry.
Smith ML; Hughes RO; Levine B; Dickerson S; Darwin WD; Cone EJ
J Anal Toxicol; 1995; 19(1):18-26. PubMed ID: 7536861
[TBL] [Abstract][Full Text] [Related]
9. The simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, 6-acetylmorphine, and oxycodone in hair and oral fluid.
Jones J; Tomlinson K; Moore C
J Anal Toxicol; 2002 Apr; 26(3):171-5. PubMed ID: 11991534
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the DRI oxycodone immunoassay for the detection of oxycodone in urine.
Backer RC; Monforte JR; Poklis A
J Anal Toxicol; 2005 Oct; 29(7):675-7. PubMed ID: 16419399
[TBL] [Abstract][Full Text] [Related]
11. Facilitation of thin-layer chromatographic identification of opiates by derivatization with acetic anhydride or methoxyamine.
Dietzen DJ; Koenig J; Turk J
J Anal Toxicol; 1995 Sep; 19(5):299-303. PubMed ID: 7500616
[TBL] [Abstract][Full Text] [Related]
12. A simplified procedure for the determination of free codeine, free morphine, and 6-acetylmorphine in urine.
Fuller DC; Anderson WH
J Anal Toxicol; 1992; 16(5):315-8. PubMed ID: 1294837
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of an opiate immunoassay for detecting hydrocodone and hydromorphone in urine from a clinical population: analysis of subthreshold results.
Bertholf RL; Johannsen LM; Reisfield GM
J Anal Toxicol; 2015; 39(1):24-8. PubMed ID: 25288720
[TBL] [Abstract][Full Text] [Related]
14. Degradation of Opioids and Opiates During Acid Hydrolysis Leads to Reduced Recovery Compared to Enzymatic Hydrolysis.
Sitasuwan P; Melendez C; Marinova M; Mastrianni KR; Darragh A; Ryan E; Lee LA
J Anal Toxicol; 2016 Oct; 40(8):601-607. PubMed ID: 27702939
[TBL] [Abstract][Full Text] [Related]
15. Improved GC/MS analysis of opiates with use of oxime-TMS derivatives.
Cremese M; Wu AH; Cassella G; O'Connor E; Rymut K; Hill DW
J Forensic Sci; 1998 Nov; 43(6):1220-4. PubMed ID: 9846400
[TBL] [Abstract][Full Text] [Related]
16. Comparison of an automated and point-of-care immunoassay to GC-MS for urine oxycodone testing in the clinical laboratory.
Haller CA; Stone J; Burke V; Branch J; Chen K; Gross S
J Anal Toxicol; 2006 Mar; 30(2):106-11. PubMed ID: 16620541
[TBL] [Abstract][Full Text] [Related]
17. Analysis of morphine and codeine in samples adulterated with Stealth.
Cody JT; Valtier S; Kuhlman J
J Anal Toxicol; 2001 Oct; 25(7):572-5. PubMed ID: 11599602
[TBL] [Abstract][Full Text] [Related]
18. Automated solid-phase extraction of opiates from urine (I).
Tay MK; Lee TK; Chui WY
Ann Acad Med Singap; 1993 Jan; 22(1):11-7. PubMed ID: 8503629
[TBL] [Abstract][Full Text] [Related]
19. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
[TBL] [Abstract][Full Text] [Related]
20. Forensic drug testing for opiates. V. Urine testing for heroin, morphine, and codeine with commercial opiate immunoassays.
Cone EJ; Dickerson S; Paul BD; Mitchell JM
J Anal Toxicol; 1993; 17(3):156-64. PubMed ID: 8336489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
